These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33434439)

  • 1. Real-World Evidence and Glycemic Improvement Using Dexcom G6 Features.
    Akturk HK; Dowd R; Shankar K; Derdzinski M
    Diabetes Technol Ther; 2021 Mar; 23(S1):S21-S26. PubMed ID: 33434439
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustainable Use of a Real-Time Continuous Glucose Monitoring System from 2018 to 2020.
    van der Linden J; Welsh JB; Walker TC
    Diabetes Technol Ther; 2021 Jul; 23(7):508-511. PubMed ID: 33567233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G6 continuous glucose monitoring system feature use and its associations with glycaemia in Europe.
    Acciaroli G; Parkin CG; Thomas R; Layne J; Norman GJ; Leone K
    Diabet Med; 2023 Jun; 40(6):e15093. PubMed ID: 36951684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert.
    Puhr S; Derdzinski M; Welsh JB; Parker AS; Walker T; Price DA
    Diabetes Technol Ther; 2019 Apr; 21(4):155-158. PubMed ID: 30896290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic Outcomes and Feature Set Engagement Among Real-Time Continuous Glucose Monitoring Users With Type 1 or Non-Insulin-Treated Type 2 Diabetes: Retrospective Analysis of Real-World Data.
    Dowd R; Jepson LH; Green CR; Norman GJ; Thomas R; Leone K
    JMIR Diabetes; 2023 Jan; 8():e43991. PubMed ID: 36602920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal analysis of users transitioning from the Dexcom G5 to the G6 RT-CGM system in Germany, Sweden and the United Kingdom (2018-2020).
    Acciaroli G; van der Linden J; Chao C; Walker TC; Oliver N
    Diabet Med; 2023 Feb; 40(2):e14946. PubMed ID: 36053809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of intraoperative continuous glucose monitoring: An observational study in general surgery patients.
    Price CE; Fanelli JE; Aloi JA; Anzola SC; Vishneski SR; Saha AK; Woody CC; Segal S
    J Clin Anesth; 2023 Aug; 87():111090. PubMed ID: 36913777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.
    Peyser TA; Nakamura K; Price D; Bohnett LC; Hirsch IB; Balo A
    Diabetes Technol Ther; 2015 Aug; 17(8):548-54. PubMed ID: 25961446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitigation of Rebound Hyperglycemia With Real-Time Continuous Glucose Monitoring Data and Predictive Alerts.
    Acciaroli G; Welsh JB; Akturk HK
    J Diabetes Sci Technol; 2022 May; 16(3):677-682. PubMed ID: 33401946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.
    Rossi A; Venema A; Haarsma P; Feldbrugge L; Burghard R; Rodriguez-Buritica D; Parenti G; Oosterveer MH; Derks TGJ
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3612-e3623. PubMed ID: 35786777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Retrospective Data Review in the Personal Use of Real-Time Continuous Glucose Monitoring: Perceived Impact on Quality of Life and Health Outcomes.
    Polonsky WH; Soriano EC; Fortmann AL
    Diabetes Technol Ther; 2022 Jul; 24(7):492-501. PubMed ID: 35255224
    [No Abstract]   [Full Text] [Related]  

  • 12. Real-World Hypoglycemia Avoidance With a Predictive Low Glucose Alert Does Not Depend on Frequent Screen Views.
    Puhr S; Derdzinski M; Parker AS; Welsh JB; Price DA
    J Diabetes Sci Technol; 2020 Jan; 14(1):83-86. PubMed ID: 30943780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Improvements in Glycemic Control with Dexcom CGM Use in Adults with Noninsulin-Treated Type 2 Diabetes.
    Layne JE; Jepson LH; Carite AM; Parkin CG; Bergenstal RM
    Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38904213
    [No Abstract]   [Full Text] [Related]  

  • 14. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.
    Wadwa RP; Laffel LM; Shah VN; Garg SK
    Diabetes Technol Ther; 2018 Jun; 20(6):395-402. PubMed ID: 29901421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
    Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
    Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts.
    Abraham SB; Arunachalam S; Zhong A; Agrawal P; Cohen O; McMahon CM
    J Diabetes Sci Technol; 2021 Jan; 15(1):91-97. PubMed ID: 31272204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
    Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
    Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
    Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
    J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.